Critical Insights From BioNTech Analyst Ratings: What You Need To Know

BenzingaMay 24 08:01 ET

BioNTech Analyst Ratings

BenzingaMay 24 06:14 ET

Analysts Conflicted on These Healthcare Names: Nektar Therapeutics (NKTR) and BioNTech SE (BNTX)

TipRanksMay 24 06:01 ET

Buy Rating on BioNTech SE Amidst Undervaluation and Strong Pipeline Prospects

TipRanksMay 24 01:50 ET

Biogen's Strategic Diversification and Financial Strategy Garner Outperform Rating

TipRanksMay 24 01:51 ET

Strategic Acquisitions and Clinical Catalysts Bolster Biogen's Buy Rating

TipRanksMay 24 01:48 ET

Biogen (BIIB) Gets a Buy From Oppenheimer

TipRanksMay 23 07:46 ET

Analysts' Top Healthcare Picks: Scholar Rock Holding (SRRK), Gilead Sciences (GILD)

TipRanksMay 23 07:20 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Biogen (BIIB) and Incyte (INCY)

TipRanksMay 23 07:11 ET

Biogen Analyst Ratings

BenzingaMay 23 06:09 ET

Wedbush Raises Biogen Price Target to $219 From $215, Maintains Neutral Rating

MT NewswiresMay 22 09:49 ET

Biogen Analyst Ratings

BenzingaMay 22 09:36 ET

Biogen's Strategic Acquisition of HI-Bio and Diversification Into Orphan Drug Market Prompt 'Buy' Rating

TipRanksMay 22 09:15 ET

Deutsche Bank Adjusts Waters Price Target to $330 From $304

MT NewswiresMay 22 08:53 ET

Gilead Sciences (GILD) Gets a Hold From Wells Fargo

TipRanksMay 22 05:45 ET

Barclays Sticks to Its Hold Rating for Amgen (AMGN)

TipRanksMay 21 03:46 ET

Jefferies Raises Regeneron Pharmaceuticals' Price Target to $1,125 From $1,115

MT NewswiresMay 20 14:49 ET

HSBC Adjusts Price Target on Amgen to $356 From $322

MT NewswiresMay 20 07:48 ET

Piper Sandler Adjusts Price Target on Regeneron Pharmaceuticals to $1,000 From $1,000.25

MT NewswiresMay 20 07:38 ET

Jefferies Raises Regeneron Pharmaceuticals' Price Target to $1,115 From $1,060

MT NewswiresMay 17 14:39 ET